STOCK TITAN

HIVE (HIVE) director gains 12,500 shares as RSUs vest, 325,000 RSUs remain

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HIVE Digital Technologies director Susan B. McGee acquired 12,500 common shares through RSU vesting. On May 5, 2026, 12,500 restricted stock units vested and settled into an equal number of common shares on a one-for-one basis. Following the transaction, she directly holds 225,000 common shares and 325,000 RSUs, which include additional awards scheduled to vest between August 2026 and March 2027.

Positive

  • None.

Negative

  • None.
Insider MCGEE SUSAN B
Role null
Type Security Shares Price Value
Exercise Restricted stock units 12,500 $0.00 --
Exercise Common Shares 12,500 $0.00 --
Holdings After Transaction: Restricted stock units — 325,000 shares (Direct, null); Common Shares — 225,000 shares (Direct, null)
Footnotes (1)
  1. Reflects restricted stock units ("RSUs") that upon vesting and settlement converted into shares of Issuer common stock on a one-for-one basis. Each RSU represents the right to receive, at settlement, one share of common stock of the Issuer. 12,500 RSUs vested on May 5, 2026. The RSUs reported under Column 9 include four additional RSU awards that were previously reported. The underlying shares and vesting schedules are as follows: (i) 25,000 vest in two equal installments of 12,500 on each of August 5, 2026 and November 5, 2026; (ii) 100,000 will vest on July 8, 2026; (iii) 100,000 will vest on October 31, 2026 and (iv) 100,000 will vest on March 16, 2027.
RSUs vested 12,500 units Vested and settled into common shares on May 5, 2026
Common shares held 225,000 shares Direct holdings after RSU conversion
RSUs outstanding 325,000 units Restricted stock units held after the transaction
Future RSU vesting tranche 25,000 units Two installments of 12,500 vest on Aug 5 and Nov 5, 2026
Single RSU vesting awards 100,000 units each Three awards vest on Jul 8, 2026; Oct 31, 2026; Mar 16, 2027
restricted stock units ("RSUs") financial
"Reflects restricted stock units ("RSUs") that upon vesting and settlement converted..."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
vesting financial
"12,500 RSUs vested on May 5, 2026."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
settlement financial
"RSUs that upon vesting and settlement converted into shares of Issuer common stock..."
Settlement is the process of completing a financial transaction, like buying or selling a stock, by transferring money and ownership between parties. It ensures that both the buyer gets the asset and the seller gets paid, making the deal official. Without settlement, the transaction wouldn't be finalized or legally recognized.
common stock of the Issuer financial
"Each RSU represents the right to receive, at settlement, one share of common stock of the Issuer."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MCGEE SUSAN B

(Last)(First)(Middle)
7900 CALLAGHAN ROAD
SUITE 128

(Street)
SAN ANTONIO TEXAS 78229

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HIVE Digital Technologies Ltd. [ HIVE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
[HIVE]
3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares05/05/2026M12,500(1)A(1)225,000D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted stock units(2)05/05/2026M12,500 (3) (3)Common Stock12,500$0325,000(4)D
Explanation of Responses:
1. Reflects restricted stock units ("RSUs") that upon vesting and settlement converted into shares of Issuer common stock on a one-for-one basis.
2. Each RSU represents the right to receive, at settlement, one share of common stock of the Issuer.
3. 12,500 RSUs vested on May 5, 2026.
4. The RSUs reported under Column 9 include four additional RSU awards that were previously reported. The underlying shares and vesting schedules are as follows: (i) 25,000 vest in two equal installments of 12,500 on each of August 5, 2026 and November 5, 2026; (ii) 100,000 will vest on July 8, 2026; (iii) 100,000 will vest on October 31, 2026 and (iv) 100,000 will vest on March 16, 2027.
/s/ Susan McGee05/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HIVE (HIVE) director Susan B. McGee report?

Susan B. McGee reported an acquisition of shares via vesting RSUs. On May 5, 2026, 12,500 restricted stock units vested and converted into 12,500 common shares, with no open-market purchase or sale, reflecting compensation-related equity rather than a trading decision.

How many HIVE (HIVE) common shares does Susan B. McGee hold after this Form 4?

After the reported transaction, Susan B. McGee directly holds 225,000 common shares. This reflects her position following the conversion of 12,500 restricted stock units into common shares on May 5, 2026, as disclosed in the Form 4 insider filing.

How many restricted stock units does Susan B. McGee hold in HIVE (HIVE)?

Following the transaction, Susan B. McGee holds 325,000 restricted stock units. These RSUs represent the right to receive one common share per unit at settlement, with portions scheduled to vest on several future dates through March 16, 2027.

What are the future RSU vesting dates disclosed for HIVE (HIVE) director Susan B. McGee?

Future RSU vesting for Susan B. McGee includes 25,000 units vesting in two 12,500 installments on August 5 and November 5, 2026, 100,000 vesting on July 8, 2026, 100,000 on October 31, 2026, and 100,000 on March 16, 2027, subject to grant terms.

How do the RSUs convert into HIVE (HIVE) common shares for Susan B. McGee?

Each restricted stock unit converts into one HIVE common share at settlement. The filing states that RSUs convert into issuer common stock on a one-for-one basis upon vesting, so 12,500 vested RSUs produced 12,500 new common shares for Susan B. McGee.

Was there any open-market buying or selling in this HIVE (HIVE) Form 4?

The Form 4 reflects derivative exercises, not open-market trades. The transaction code “M” and a zero price per share indicate RSU vesting and conversion into common shares, with no reported open-market purchases or sales in this filing.